Sangamo appoints Courtney Beers and Margaret Horn to board; grants equity awards

SANGAMO THERAPEUTICS, INC

Courtney Beers (Ph.D.) and Margaret A. Horn appointed to board effective Dec 15, 2022; Dr. Beers joins Compensation Committee, Ms. Horn joins Nominating Committee.
Each received automatic grant: option to purchase 37,500 shares at $3.30 (Dec 15 closing price) vesting over 36 months, and RSU of 18,750 shares vesting in 3 annual installments.
Board approved Fifth Amended and Restated Bylaws; includes updates for universal proxy rules (Rule 14a-19), Delaware exclusive forum, and stockholder proposal procedures.
Standard indemnification agreements entered with each new director.

item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Margaret A. Horn

Director

SGMO · SANGAMO THERAPEUTICS, INC

Effective: 2022-12-15
Filed: December 19, 2022, 6:59 PM ET

On December 15, 2022, the Board of Directors (the “Board”) of Sangamo Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Courtney Beers, Ph.D., and Margaret A. Horn to serve as directors of the Board until the Company’s next annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier deaths, resignations or removals.

Appointed

Courtney Beers

Director

SGMO · SANGAMO THERAPEUTICS, INC

Effective: 2022-12-15
Filed: December 19, 2022, 6:59 PM ET

On December 15, 2022, the Board of Directors (the “Board”) of Sangamo Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Courtney Beers, Ph.D., and Margaret A. Horn to serve as directors of the Board until the Company’s next annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier deaths, resignations or removals.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Margaret A. Horn was appointed as Director at SANGAMO THERAPEUTICS, INC.

Action: appointed
Role: Director

Exact text from the filing

On December 15, 2022, the Board of Directors (the “Board”) of Sangamo Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Courtney Beers, Ph.D., and Margaret A. Horn to serve as directors of the Board until the Company’s next annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier deaths, resignations or removals.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Courtney Beers was appointed as Director at SANGAMO THERAPEUTICS, INC.

Action: appointed
Role: Director

Exact text from the filing

On December 15, 2022, the Board of Directors (the “Board”) of Sangamo Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Courtney Beers, Ph.D., and Margaret A. Horn to serve as directors of the Board until the Company’s next annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier deaths, resignations or removals.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SANGAMO THERAPEUTICS, INC: The Board approved and adopted the Fifth Amended and Restated Bylaws, effective immediately, making updates to stockholder meeting procedures, forum selection, indemnification, universal proxy rules, and other administrative revisions (effective 2022-12-15).

Change: bylaw amendment
Effective: 2022-12-15

Exact text from the filing

On December 15, 2022, the Board, acting upon the recommendation of the Nominating Committee, approved and adopted an amendment and restatement of the Fourth Amended and Restated Bylaws of the Company (as so amended and restated, the “Fifth Amended and Restated Bylaws”), effective immediately.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

SANGAMO THERAPEUTICS, INC filing history →

Source: SEC EDGAR

accession 0001628280-22-032209

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.